High-Purity 4-(Pyridin-2-yl-aminocarbonyl)benzeneboronic Acid: A Key Intermediate for Acalabrutinib Synthesis

Discover the critical role of 4-(Pyridin-2-yl-aminocarbonyl)benzeneboronic acid in advanced pharmaceutical synthesis. As a leading manufacturer and supplier, we provide high-quality intermediates essential for producing novel therapeutics like Acalabrutinib. Explore our offerings and secure your supply chain.

Get a Quote & Sample

Advantages of Partnering With Us

Reliable Supply Chain

As a dedicated supplier of pharmaceutical intermediates, we ensure a stable and consistent supply of 4-(pyridin-2-yl-aminocarbonyl)benzeneboronic acid, allowing your production to run without interruption. Buy with confidence from our China-based operations.

Quality Assurance

Our commitment to quality means every batch of 4-(pyridin-2-yl-aminocarbonyl)benzeneboronic acid meets stringent specifications, backed by rigorous testing and adherence to industry standards. Essential for your Acalabrutinib synthesis.

Competitive Pricing & Support

We offer competitive prices for our pharmaceutical intermediates and provide comprehensive technical support. Contact us today to inquire about pricing and bulk purchase options for this critical Acalabrutinib intermediate.

Core Application Areas

Pharmaceutical Synthesis

Essential intermediate for the synthesis of Acalabrutinib, a targeted therapy. Secure your supply of this high-purity boronic acid for your pharmaceutical manufacturing needs.

BTK Inhibitor Development

Crucial building block for research and development of Bruton's tyrosine kinase (BTK) inhibitors, advancing cancer and autoimmune disease treatments.

Custom Chemical Synthesis

Leverage our expertise as a custom synthesis provider for your specific project requirements involving boronic acid derivatives and complex intermediates.

API Intermediate Sourcing

Reliable sourcing solution for Actuve Pharmaceutical Ingredient (API) intermediates. We simplify the procurement process for critical chemical building blocks.